Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Standard Dose
325MG;50MG;40MG;30MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE is listed in Drugs@FDA under application 203335 (ANDA).

Marketing status: Discontinued Active ingredient ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;50MG;40MG;30MG Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2018-09-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE is listed in Drugs@FDA under application 203335 (ANDA). Marketing status: Discontinued Active ingredient ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE Form and strength CAPSULE;ORAL - 325MG;50MG;40MG;30MG Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2018-09-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.